论文部分内容阅读
我国现行的药品专利保护制度规定过于严格,没有充分利用TRIPS协定的弹性条款。经过《多哈宣言》和《关于实施TRIPS协定与公共健康多哈宣言第六段的决议》以及争端解决机制的解释和检验,TRIPS协定原本模糊的保障措施在可操作性上获得了提高。我国的相关立法应当适时进行相应地调整,以充分利用TRIPS协定保障措施所给予的空间,实现对我国专利药品的全面保护,提高药品的可及性,促进民族制药行业的发展。
China’s current drug patent protection system is too strict, did not make full use of the flexible provisions of the TRIPS agreement. After the Doha Declaration and the Resolution on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, as well as the interpretation and testing of the dispute settlement mechanism, the original vague safeguard of the TRIPS Agreement has been improved in operability. China’s relevant legislation should be adjusted accordingly in a timely manner to make full use of the space given by the TRIPS safeguards, to achieve the full protection of the patented drugs in our country, to improve the accessibility of the drugs and to promote the development of the national pharmaceutical industry.